Capstone Investment Advisors, LLC Immunocore Holdings PLC Transaction History
Capstone Investment Advisors, LLC
- $35.4 Billion
- Q1 2025
A detailed history of Capstone Investment Advisors, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 17,200 shares of IMCR stock, worth $549,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,200
Previous 17,200
-0.0%
Holding current value
$549,196
Previous $507,000
0.59%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMCR
# of Institutions
134Shares Held
44.7MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$225 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$196 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$85.5 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74.2 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...